Cogent Biosciences, Inc.
COGT
Revenue
0.00
0.000.00%
-Assets
327.90M
▼-56.12M▼-14.61%
3 Months ChangeLiabilities
71.61M
▲2.26M▲3.25%
3 Months ChangeFree Cash Flow
-52.60M
▼-11.98M▼-29.49%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-03
Form 8-K
ID: 0001193125-24-211584
2024-08-06
Form 10-Q
ID: 0000950170-24-091229
2024-08-06
Form 8-K
ID: 0000950170-24-091220
2024-06-27
Form 8-K
ID: 0001193125-24-169756
2024-06-05
Form 8-K
ID: 0001193125-24-155116
2024-05-07
Form 10-Q
ID: 0000950170-24-053977
2024-05-07
Form 8-K
ID: 0000950170-24-053974
2024-03-22
Form 8-K
ID: 0001193125-24-074628
2024-02-26
Form 8-K
ID: 0000950170-24-019754
2024-02-14
Form 8-K
ID: 0001193125-24-035203